Colm Cunningham, Ph.D.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Exalys Therapeutics
    Topic:
    Post-operative cognitive dysfunction
    Date added:
    05/19/2023
    Date updated:
    05/30/2024
    Relationship end date:
    06/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    IONIS Therapeutics
    Topic:
    Microglial activation and delirium
    Date added:
    05/19/2023
    Date updated:
    05/30/2024
    Relationship end date:
    06/14/2023
Return to 0042_ADS_13th Annual Conference of the American Delirium Society_Live